HK1199891A1 - Rapid method for cloning and expression of cognate antibody variable region gene segments - Google Patents

Rapid method for cloning and expression of cognate antibody variable region gene segments

Info

Publication number
HK1199891A1
HK1199891A1 HK15100396.3A HK15100396A HK1199891A1 HK 1199891 A1 HK1199891 A1 HK 1199891A1 HK 15100396 A HK15100396 A HK 15100396A HK 1199891 A1 HK1199891 A1 HK 1199891A1
Authority
HK
Hong Kong
Prior art keywords
cloning
expression
variable region
gene segments
antibody variable
Prior art date
Application number
HK15100396.3A
Other languages
English (en)
Chinese (zh)
Inventor
Simone Hoege
Erhard Kopetzki
Dominique Ostler
Stefan Seeber
Georg Tiefenthaler
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47522537&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1199891(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK1199891A1 publication Critical patent/HK1199891A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0635—B lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Analytical Chemistry (AREA)
HK15100396.3A 2011-12-21 2015-01-14 Rapid method for cloning and expression of cognate antibody variable region gene segments HK1199891A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11194861 2011-12-21
PCT/EP2012/076155 WO2013092716A1 (en) 2011-12-21 2012-12-19 Rapid method for cloning and expression of cognate antibody variable region gene segments

Publications (1)

Publication Number Publication Date
HK1199891A1 true HK1199891A1 (en) 2015-07-24

Family

ID=47522537

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15100396.3A HK1199891A1 (en) 2011-12-21 2015-01-14 Rapid method for cloning and expression of cognate antibody variable region gene segments

Country Status (12)

Country Link
US (3) US20140302559A1 (xx)
EP (1) EP2794652B1 (xx)
JP (3) JP2015500655A (xx)
KR (1) KR20140104963A (xx)
CN (2) CN109810188A (xx)
BR (1) BR112014013034A2 (xx)
CA (1) CA2854243A1 (xx)
HK (1) HK1199891A1 (xx)
MX (1) MX354049B (xx)
RU (1) RU2612910C2 (xx)
SG (1) SG11201403365TA (xx)
WO (1) WO2013092716A1 (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010115589A1 (en) 2009-04-07 2010-10-14 Roche Glycart Ag Trivalent, bispecific antibodies
US9676845B2 (en) 2009-06-16 2017-06-13 Hoffmann-La Roche, Inc. Bispecific antigen binding proteins
RU2573915C2 (ru) 2009-09-16 2016-01-27 Дженентек, Инк. Содержащие суперспираль и/или привязку белковые комплексы и их применение
AR080793A1 (es) 2010-03-26 2012-05-09 Roche Glycart Ag Anticuerpos biespecificos
CA2807278A1 (en) 2010-08-24 2012-03-01 F. Hoffmann - La Roche Ag Bispecific antibodies comprising a disulfide stabilized - fv fragment
EP2655413B1 (en) 2010-12-23 2019-01-16 F.Hoffmann-La Roche Ag Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery
RU2607038C2 (ru) 2011-02-28 2017-01-10 Ф. Хоффманн-Ля Рош Аг Антигенсвязывающие белки
CA2824824A1 (en) 2011-02-28 2012-09-07 F. Hoffmann-La Roche Ag Monovalent antigen binding proteins
JP2015500655A (ja) * 2011-12-21 2015-01-08 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 同起源の抗体可変領域遺伝子セグメントをクローニングおよび発現させるための迅速な方法
JP6486686B2 (ja) 2012-02-10 2019-03-20 ジェネンテック， インコーポレイテッド 単鎖抗体及び他のヘテロ多量体
CA2871882A1 (en) 2012-06-27 2014-01-03 F. Hoffmann-La Roche Ag Method for making antibody fc-region conjugates comprising at least one binding entity that specifically binds to a target and uses thereof
CN104395339A (zh) 2012-06-27 2015-03-04 弗·哈夫曼-拉罗切有限公司 用于选择并产生含有至少两种不同结合实体的定制高度选择性和多特异性靶向实体的方法及其用途
US20160075766A1 (en) * 2013-05-21 2016-03-17 Roche Diagnostics Operations, Inc. Method for producing antibodies using ovine b-cells and uses thereof
EP3055329B1 (en) 2013-10-11 2018-06-13 F. Hoffmann-La Roche AG Multispecific domain exchanged common variable light chain antibodies
CA2914595C (en) * 2014-05-19 2022-12-13 F. Hoffmann-La Roche Ag Method for producing antibodies using ovine b-cells and uses thereof
JP6721590B2 (ja) 2014-12-03 2020-07-15 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 多重特異性抗体
EP4273232A3 (en) 2016-03-30 2024-01-03 F. Hoffmann-La Roche AG B-cell cultivation method
MY201744A (en) * 2016-12-23 2024-03-15 Visterra Inc Binding polypeptides and methods of making the same
EP3562936B1 (en) 2017-01-02 2024-05-22 F. Hoffmann-La Roche AG B-cell cultivation method

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9815909D0 (en) * 1998-07-21 1998-09-16 Btg Int Ltd Antibody preparation
CN100383244C (zh) * 2003-01-07 2008-04-23 西福根有限公司 用于生产重组多克隆蛋白质的方法
US20060051348A1 (en) 2004-09-09 2006-03-09 Jorn Gorlach Method of producing a plurality of isolated antibodies to a plurality of cognate antigens
WO2007031550A2 (en) 2005-09-15 2007-03-22 Crucell Holland B.V. Method for preparing immunoglobulin libraries
EP2021463B1 (en) 2006-05-19 2016-11-23 Alder Biopharmaceuticals, Inc. Culture method for obtaining a clonal population of antigen-specific b cells
LT2164514T (lt) 2007-05-21 2017-03-10 Alderbio Holdings Llc Il-6 antikūnai ir jų naudojimas
CN102272158B (zh) 2008-11-12 2014-05-07 乔治·K·刘易斯 源自记忆b细胞的人单克隆抗体的快速表达克隆
US8609097B2 (en) * 2009-06-10 2013-12-17 Hoffmann-La Roche Inc. Use of an anti-Tau pS422 antibody for the treatment of brain diseases
AU2010317609A1 (en) * 2009-11-16 2012-07-05 Acyte Biotech Pty Ltd Recombinant antibody vector
US20110223176A1 (en) * 2010-03-11 2011-09-15 Abbott Laboratories Basigin binding proteins
DK2400298T3 (da) * 2010-05-28 2013-09-02 Hoffmann La Roche Enkelt B-celle-dyrkningsfremgangsmåde og specifik antistoffremstilling
JP2015500655A (ja) * 2011-12-21 2015-01-08 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 同起源の抗体可変領域遺伝子セグメントをクローニングおよび発現させるための迅速な方法

Also Published As

Publication number Publication date
US20170210785A1 (en) 2017-07-27
JP2019162144A (ja) 2019-09-26
WO2013092716A1 (en) 2013-06-27
JP2015500655A (ja) 2015-01-08
BR112014013034A2 (pt) 2017-12-19
EP2794652A1 (en) 2014-10-29
US12024548B2 (en) 2024-07-02
JP2017221190A (ja) 2017-12-21
MX354049B (es) 2018-02-09
US20190382469A1 (en) 2019-12-19
US20140302559A1 (en) 2014-10-09
RU2014128987A (ru) 2016-02-20
CA2854243A1 (en) 2013-06-27
CN109810188A (zh) 2019-05-28
RU2612910C2 (ru) 2017-03-13
CN104011074A (zh) 2014-08-27
KR20140104963A (ko) 2014-08-29
MX2014007256A (es) 2014-08-01
SG11201403365TA (en) 2014-07-30
JP6573331B2 (ja) 2019-09-11
EP2794652B1 (en) 2017-11-15

Similar Documents

Publication Publication Date Title
HK1199891A1 (en) Rapid method for cloning and expression of cognate antibody variable region gene segments
HK1252157A1 (zh) 重組病毒產品和抑制dux4表達的方法
IL231259A0 (en) A furnace with a high diagnosis and a method of operation
ZA201309287B (en) Methods and compositions for selective regulation of protein expression
EP2691121A4 (en) COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF TMPRSS6 GENE
HUE062196T2 (hu) Eljárás egyesítési lista szerkesztésére
EP2662385A4 (en) METHOD FOR IMPROVING THE PHYSICAL PROPERTIES OF ANTIBODIES
GB201103450D0 (en) Apparatus and method of manipulation of articles
SG11201400405TA (en) Caninised antibodies and method for the production of same
HK1201537A1 (en) Anti-kdr antibodies and methods of use -kdr
IL228073A0 (en) Method for the determination of polysorbate
EP2745678A4 (en) PROCESS FOR CONTROLLING THE REPRODUCTION OF HOPPING
EP2699673A4 (en) RECOMBINANT VIRUS PRODUCTS AND METHODS FOR EXPRESSION INHIBITION OF MYOTILINE
LT2701707T (lt) Diskinezijos gydymo būdas
EP2663662A4 (en) STAHLENTSCHWEFELUNGSVERFAHREN
ZA201306212B (en) An improved process for the preparation of voriconazole and intermediates thereof
EP2726652A4 (en) PROCESS FOR PROTEIN DISPLAY
GB2497108B (en) Laser system and associated method of operation
HK1184173A1 (en) Anti-kdr antibodies and methods of use -kdr
GB2487128B (en) Carton and method of assembly thereof
EP2774995A4 (en) METHOD OF MEASURING THE ABUNDANCE OF GENES
EP2707569A4 (en) DORN ARRANGEMENT AND OPERATING PROCEDURE THEREFOR
AU2011902463A0 (en) Method of Desulfurizing Steel
AU2011905262A0 (en) Method of blasting